Latest News about PFE
Recent news which mentions PFE
From Benzinga
 
   Pfizer's Q3 Earnings Surpasses Estimates, Lifts Forecasts For COVID-19 Vaccine Sales By $2B
   
  November 01, 2022
  Tickers 
   PFE
  
  
  From Benzinga
 
   Pfizer climbs on strong Q3 results, raised outlook
   
  
  
  November 01, 2022
  From MarketWatch
 
   This reliable indicator of recession has yet to buckle, and so the Fed won’t either, strategist says
   
  
  
  November 01, 2022
  From MarketWatch
 From Benzinga
 
   Earnings Scheduled For November 1, 2022
   
  
  
  November 01, 2022
  From Benzinga
 
   Pfizer, Eli Lilly And 3 Stocks To Watch Heading Into Tuesday
   
  
  
  November 01, 2022
  From Benzinga
 
   Dow futures climb as traders jostle for position before Fed decision
   
  
  
  November 01, 2022
  From MarketWatch
 
   7 Cash-Rich Dividend Stocks to Buy Now
   
  
  
  November 01, 2022
  From InvestorPlace
 
   After FDA, European Agency Limits Use Of Certain JAK Inhibitors Amid Safety Concerns
   
  
  
  October 31, 2022
  From Benzinga
 
   New omicron subvariants accounted for 42.5% of cases in New York region in latest week, CDC data shows
   
  
  
  October 31, 2022
  From MarketWatch
 
   The S&P 500 can get to 4,150 before ‘reality sets in,’ says Morgan Stanley’s normally bearish top strategist
   
  
  
  October 31, 2022
  From MarketWatch
 
   Why Moderna Stock Soared Last Week
   
  
  
  October 30, 2022
  From Motley Fool
 From MarketWatch
 
   Why Shares of Vaxcyte Rose 110.7% This Week
   
  
  
  October 29, 2022
  From Motley Fool
 From Benzinga
 
   Why Inovio Pharmaceuticals Stock Zoomed Nearly 6% Higher Today
   
  
  
  October 28, 2022
  From Motley Fool
 From Benzinga
 
   National Institutes of Health's Long COVID Initiative To Assess Pfizer's Antiviral Pill As Potential Treatment
   
  October 28, 2022
  Tickers 
   PFE
  
  
  From Benzinga
 From InvestorPlace
 From Benzinga
 
   Pfizer Says Its Minority Fellowship Program Serves Public Interest, In Defending Lawsuit
   
  October 27, 2022
  Tickers 
   PFE
  
  
  From Benzinga
 
   Is BioNTech a Good Long-Term Buy?
   
  
  
  October 27, 2022
  From Motley Fool
 From Motley Fool
 
   Walt Disney, Honeywell International, Regions Financial And This Pharma Giant Featured On CNBC's Final Trade
   
  
  
  October 25, 2022
  From Benzinga
 
   Could This News from Pfizer Equal Billions for Moderna?
   
  
  
  October 25, 2022
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

